Verity & Verity, LLC Novartis Ag Transaction History

Verity & Verity, LLC

$1.63 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Jun 21, 2021	SELL	$83.5 - $98.47 $264,945 - $312,445	-3,173 Closed	0 $0
Q4 2020 Jan 12, 2021	SELL	$78.07 - $94.43 $16,785 - $20,302	-215 Reduced 6.35%	3,173 $299,000
Q3 2020 Oct 06, 2020	SELL	$82.14 - $91.0 $5.24 Million - $5.81 Million	-63,824 Reduced 94.96%	3,388 $299,000
Q2 2020 Jul 14, 2020	SELL	$80.93 - $91.1 $64,582 - $72,697	-798 Reduced 1.17%	67,212 $5.79 Million
Q1 2020 Apr 09, 2020	SELL	$70.67 - $99.01 $358,791 - $502,673	-5,077 Reduced 6.95%	68,010 $5.61 Million

Q4 2019 Jan 08, 2020	SELL	$84.35 - $95.37 $264,099 - $298,603	-3,131 Reduced 4.11%	73,087 $6.92 Million
Q3 2019 Oct 11, 2019	SELL	$85.54 - $94.26 $99,654 - $109,812	-1,165 Reduced 1.51%	76,218 $6.53 Million
Q2 2019 Jul 17, 2019	SELL	$75.4 - $92.8 $1.44 Million - $1.78 Million	-19,145 Reduced 19.83%	77,383 $7.07 Million
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $889,077 - $1.02 Million	-11,804 Reduced 10.9%	96,528 $9.28 Million
Q4 2018 Jan 16, 2019	BUY	$73.66 - $82.02 $8,323 - $9,268	113 Added 0.1%	108,332 $9.3 Million
Q3 2018 Oct 16, 2018	SELL	$66.94 - $77.43 $19,747 - $22,841	-295 Reduced 0.27%	108,219 $9.32 Million
Q2 2018 Jul 20, 2018	SELL	$64.91 - $73.36 $85,616 - $96,761	-1,319 Reduced 1.2%	108,514 $8.77 Million
Q2 2018 Jul 20, 2018	BUY	$64.91 - $73.36 $85,616 - $96,761	1,319 Added 1.22%	109,833 $8.3 Million
Q1 2018 Apr 25, 2018	BUY	$70.39 - $84.15 $66,236 - $79,185	941 Added 0.87%	108,514 $8.77 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $104,372 - $112,034	1,443 Added 1.36%	107,573 $9.03 Million
Q3 2017 Oct 31, 2017	BUY	$74.14 - $77.27 $7.87 Million - $8.2 Million	106,130	106,130 $9.11 Million

Others Institutions Holding NVS

# of Institutions

1,351

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $233B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity & Verity, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verity & Verity, LLC with notifications on news.

Account